MRC CiC - Development of the novel ferronucleoside TUC-1 as a new therapy for pancreatic cancer
Project: Research Councils
Participants
- Nikolas Hodges (Principal Investigator)
- Jim Tucker (Co-Investigator)
Colleges, School and Institutes
Short title | MRC CiC - Development of the novel ferronucleoside TUC-1 as a new therapy for pancreatic cancer |
---|---|
Status | Finished |
Effective start/end date | 1/10/17 → 1/10/18 |